Insulet Corporation
NASDAQ:PODDMedical - Devices
-$4.17 today
- Market cap
- $9.71B
- Beta
- 1.13
- P/E (TTM)
- 33.2
- EPS (TTM)
- $4.33
Volume 2.09M
Average 1.32M
PODD Account Payables
Amounts the company owes suppliers for goods and services received.
Insulet CorporationNASDAQ: PODD
Account Payables · Q2 FY2026 · quarter ended Jun 2026
Account payables rises 28.3% from a year ago
Account payables stood at $123.3M at the end of Q2 FY2026, up 28.3% from a year earlier and down 17.7% from the prior quarter. Over 3 fiscal years it compounded at +34.5% a year.
Context
- Account payables amounted to 3.9% of total assets at the end of Q2 FY2026, up 1.1 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +28.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 75M USD
- Year-over-year change
- +278.8%
- 4-year CAGR
- +18.8%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 75M | +278.8% |
| FY2024 | 2024-12-31 | 19.8M | +3.1% |
| FY2023 | 2023-12-31 | 19.2M | -37.7% |
| FY2022 | 2022-12-31 | 30.8M | -18.3% |
| FY2021 | 2021-12-31 | 37.7M | — |
Account Payables vs competitors
How PODD compares with its peers on the latest reported figures
- PODD's Jun 2026 account payables of $123.3M is the 2nd highest of the 5 companies compared; the peer median is $31.52M.
- Its year-over-year change of +28.3% is the 2nd highest of 5, against a peer median of -5.1%.
- Account payables amounts to 3.9% of total assets for PODD, versus a peer median of 4.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $423.8M | -10.2% | +13.1% | 6.6% | |
| Jun 2026 | $123.3M | +28.3% | +34.5% | 3.9% | |
| Mar 2026 | $59.86M | +0.1% | -5.5% | 5.2% | |
| Mar 2026 | $3.19M | +58.8% | +113.2% | 3.1% | |
| Mar 2026 | $2.32M | -32.9% | +126.5% | 0.8% | |
| Peer median (excluding PODD) | $31.52M | -5.1% | +63.1% | 4.1% | |
Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 791.6M | 623.9M | 650.7M | 953.4M | 716.1M |
| Short-term Investments | 0 | 50.8M | 53.5M | 0 | 0 |
| Net Receivables | 161M | 205.6M | 359.7M | 365.5M | 516.9M |
| Inventory | 303.2M | 346.8M | 402.6M | 430.4M | 452.6M |
| Other Current Assets | 60.7M | 71.7M | 99.8M | 121.9M | 203.1M |
| Total Current Assets | 1.32B | 1.3B | 1.57B | 1.87B | 1.89B |
| Property, Plant & Equipment (Net) | 546.4M | 625.9M | 692.8M | 759.8M | 863.2M |
| Goodwill | 39.8M | 51.7M | 51.7M | 51.5M | 51.6M |
| Intangible Assets | 36.6M | 75.5M | 98.7M | 98.5M | 117.1M |
| Long-term Investments | 19.3M | 15M | 0 | 5.5M | 20.1M |
| Tax Assets | 0 | 0 | 0 | 141.8M | 82.4M |
| Other Non-current Assets | 90.2M | 184.2M | 178.7M | 159.4M | 167.3M |
| Total Non-current Assets | 732.3M | 952.3M | 1.02B | 1.22B | 1.3B |
| Total Assets | 2.05B | 2.25B | 2.59B | 3.09B | 3.19B |
| Account Payables | 37.7M | 30.8M | 19.2M | 19.8M | 75M |
| Short-term Debt | 30.1M | 31.1M | 52.9M | 85.9M | 22.2M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.5M | 16.1M | 15.4M | 12M | 14M |
| Other Current Liabilities | 87.2M | 190.8M | 241.7M | 267.9M | 359.7M |
| Total Current Liabilities | 228.8M | 364.7M | 451.2M | 528.4M | 680.1M |
| Long-term Debt | 1.25B | 1.37B | 1.37B | 1.3B | 979.7M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 1.5M | 1.6M | 1.9M | 2M | 1.5M |
| Other Non-current Liabilities | 5.8M | 6.7M | 6.5M | 9.6M | (35M) |
| Total Non-current Liabilities | 1.26B | 1.41B | 1.4B | 1.35B | 995.1M |
| Total Liabilities | 1.49B | 1.77B | 1.86B | 1.88B | 1.68B |
| Common Stock | 100K | 100K | 100K | 100K | 100K |
| Retained Earnings | (649.5M) | (584.3M) | (378M) | 40.3M | 287.4M |
| Accumulated OCI | (2.2M) | 20M | 8M | (13.2M) | 13.2M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 556.3M | 476.4M | 732.7M | 1.21B | 1.52B |
| Total Debt | 1.29B | 1.43B | 1.45B | 1.42B | 1.05B |
| Net Debt | 494.9M | 808.9M | 798.1M | 468.6M | 334.7M |
Insulet Corporation
NASDAQ:PODD
Intrinsic Alpha fair value
Locked
Current Price
$139.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.